Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

UPC — Universe Pharmaceuticals INC Dilution Risk Tracker

Track UPC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UPC — Get alerts when the score changes →

As of August 28, 2026, Universe Pharmaceuticals INC (UPC) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Universe Pharmaceuticals INC has a market capitalization of $2.27M, 563.3K shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track UPC — Get forecast alerts →

Market Data

Market Cap$2.27M
Shares Outstanding563.3K
Float491.4K
Cash$16.76M
Debt$2.11B
Short InterestN/A

Institutional Holdings

0.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track UPC for full holder detail →

Short Interest

Short Interest6.4K
Days to Cover1.0
% of Float1.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track UPC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UPC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for UPC
UPC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.